225 related articles for article (PubMed ID: 15722898)
1. Radiotracer development in psychiatry.
Pimlott SL
Nucl Med Commun; 2005 Mar; 26(3):183-8. PubMed ID: 15722898
[TBL] [Abstract][Full Text] [Related]
2. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
3. Human Positron Emission Tomography Neuroimaging.
Hooker JM; Carson RE
Annu Rev Biomed Eng; 2019 Jun; 21():551-581. PubMed ID: 31167104
[TBL] [Abstract][Full Text] [Related]
4. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
6. Applications of positron emission tomography in psychiatry.
Parsey RV; Mann JJ
Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
[TBL] [Abstract][Full Text] [Related]
8. Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.
Kong FL; Kim EE; Yang DJ
Cancer Biother Radiopharm; 2012 Mar; 27(2):105-12. PubMed ID: 21877909
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Radiotracer properties determined by high performance liquid chromatography: a potential tool for brain radiotracer discovery.
Tavares AA; Lewsey J; Dewar D; Pimlott SL
Nucl Med Biol; 2012 Jan; 39(1):127-35. PubMed ID: 21958855
[TBL] [Abstract][Full Text] [Related]
11. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
12. ¹¹C-labeled analogs of indomethacin esters and amides for brain cyclooxygenase-2 imaging: radiosynthesis, in vitro evaluation and in vivo characteristics in mice.
Yamamoto Y; Toyohara J; Ishiwata K; Sano K; Yamamoto F; Mukai T; Maeda M
Chem Pharm Bull (Tokyo); 2011; 59(8):938-46. PubMed ID: 21804236
[TBL] [Abstract][Full Text] [Related]
13. Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist.
Rotstein BH; Liang SH; Belov VV; Livni E; Levine DB; Bonab AA; Papisov MI; Perlis RH; Vasdev N
Molecules; 2015 May; 20(6):9550-9. PubMed ID: 26016546
[TBL] [Abstract][Full Text] [Related]
14. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development.
Sobrio F; Gilbert G; Perrio C; Barré L; Debruyne D
Mini Rev Med Chem; 2010 Aug; 10(9):870-86. PubMed ID: 20504276
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceuticals in neurological and psychiatric disorders.
Valotassiou V; Wozniak G; Sifakis N; Demakopoulos N; Georgoulias P
Curr Clin Pharmacol; 2008 May; 3(2):99-107. PubMed ID: 18690884
[TBL] [Abstract][Full Text] [Related]
16. [11C]NS8880, a promising PET radiotracer targeting the norepinephrine transporter.
Vase KH; Peters D; Nielsen EØ; Alstrup AK; Bender D
Nucl Med Biol; 2014 Oct; 41(9):758-64. PubMed ID: 25127515
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain.
Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF
Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF
Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811
[TBL] [Abstract][Full Text] [Related]
19. [Use of PET and SPECT in psychiatry].
Gründer G; Vernaleken I; Bartenstein P
Nervenarzt; 2010 Jan; 81(1):97-107; quiz 108. PubMed ID: 20066394
[TBL] [Abstract][Full Text] [Related]
20. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
